Programmed cell death is a crucial process in the normal development and physiology of metazoans, and it can be divided into several categories that include type I death (apoptosis) and type II death (autophagic cell death). The Bcl-2 family proteins are well-characterized regulators of apoptosis, among which multidomain pro-apoptotic members (such as Bax and Bak) function as a mitochondrial gateway at which various apoptotic signals converge. Although embryonic fibroblasts from Bax/Bak doubleknockout (DKO) mice are resistant to apoptosis, we have previously reported that these cells still die by autophagy in response to various death stimuli. In this study, we found that jun N-terminal kinase (JNK) was activated in etoposide-and staurosporine-treated, but not serumstarved, Bax/Bak DKO cells, and that autophagic cell death was suppressed by the addition of a JNK inhibitor and by a dominant-negative mutant of JNK. Studies with sek1
Introduction
Programmed cell death is a genetically regulated mechanism of cell death, which is essential for various biological events, such as morphogenesis and the elimination of potentially harmful cells. Apoptosis is a representative form of programmed cell death, which is regulated by the Bcl-2 family proteins and driven by a family of cysteine proteases called caspases, which have already been intensively investigated. In addition, accumulating evidence suggests that other mechanisms may also contribute to programmed cell death. One of these non-apoptotic death mechanisms may be the so-called 'autophagic cell death' or type II programmed cell death, which is morphologically defined as deaths of cells associated with autophagic changes (Clarke, 1990; Baehrecke, 2002) .
Autophagy is an evolutionarily conserved process, which operates constitutively to allow bulk degradation of cellular constituents and organelles in healthy cells, and it is induced above basal levels in response to various stimuli that include starvation, genotoxic stress and deprivation of cytokines (Ohsumi, 2001; Mizushima et al., 2002; Klinonsky, 2005) . During the process of autophagy, cellular cytoplasm and organelles are engulfed by double-membrane vesicles called autophagosomes that fuse with lysosomes to become autolysosomes, in which the cargo of the autophagosomes are degraded by lysosomal enzymes. Studies performed in yeasts have revealed more than 30 molecules that are involved in autophagy, including Atg5 and Atg6 (also called Beclin 1), and homologues for these molecules have been found in mammals, providing us with clues to study the physiological process of autophagy (Ohsumi, 2001; Mizushima et al., 2002; Klinonsky, 2005) .
Autophagy is primarily a pro-survival mechanism, but there is evidence to suggest that it also functions as a pro-death mechanism under certain conditions (Levine and Yuan, 2005) . We previously discovered that embryonic fibroblasts from Bax/Bak double-knockout (DKO) mice are resistant to apoptosis, but still die in a non-apoptotic manner with autophagic features after death stimulation . We have also shown that such non-apoptotic death of Bax/Bak DKO cells is suppressed by inhibitors of autophagy, including a type III phosphoinositide-3 kinase inhibitor, 3-methyl adenine (3-MA), and is dependent on autophagic proteins, such as Atg5 and Beclin 1, indicating that this form of cell death occurs through autophagic machinery . Similarly, Lenardo and colleagues have demonstrated the induction of autophagic cell death when L929 cells were treated with benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (zVADfmk), a broad-spectrum caspase inhibitor (Yu et al., 2004) . Similar to etoposide-treated Bax/Bak DKO mouse embryonic fibroblasts (MEFs), zVAD-fmktreated L929 cells die of autophagy, and this form of cell death is blocked by silencing of Atg7 and Beclin 1 (Yu et al., 2004) . In both cases, molecules involved in autophagy apparently promote cell death rather than cell survival. When cells are starved, death eventually occurs because of autophagy, but it does not depend on autophagic proteins. Therefore, there are two kinds of autophagy-related cell death, with one being dependent on autophagy and the other being death that is not driven by autophagy. To understand the physiological and pathological roles of autophagic cell death, particularly the autophagy-dependent form of death, it is necessary to elucidate how autophagic molecules are involved in cellular destruction and to find the other molecules that also have a role in this form of cell death. Accordingly, we searched for molecules that were involved in the autophagic death of Bax/Bak DKO MEFs. As a result, we demonstrated that activation of jun N-terminal kinase (JNK) was required for the autophagic death of these cells and that such activation occurred downstream of the autophagic process itself.
Results
Phosphorylation of JNK during etoposide-induced and staurosporine-induced autophagic death of Bax/Bak DKO MEFs Recently, we showed that various apoptotic stimuli, including etoposide and staurosporine, were able to induce the autophagic death of Bax/Bak DKO MEFs , in which mitochondria-mediated apoptosis signaling is blocked. However, detailed mechanisms underlying this form of cell death were unclear. As JNK was reported to have a crucial role in inducing the autophagic death of zVAD-fmk-treated L929 cells (Yu et al., 2004) , we assumed that JNK might act as a pivotal signaling molecule for etoposide (or staurosporine)-induced autophagic death of Bax/Bak DKO MEFs. As shown in Figure 1 , the activation of JNK was detected in etoposide-treated Bax/Bak DKO MEFs by the in vitro kinase assay ( Figure 1a) and by western blot analysis of phospho-JNK (Figure 1b) . Addition of SP600125, a JNK inhibitor, prevented the phosphorylation of JNK (Figure 1b) . Similar results were obtained with staurosporine (Figure1a; data not shown). Although phosphorylated/active JNK showed molecular sizes of both 46 and 54 kD on western blotting, the 46-kD phosphorylated JNK was dominant in etoposide-treated and staurosporine-treated Bax/Bak DKO MEFs (Figure1b; data not shown). Etoposide caused immediate and sustained activation of JNK with a peak after 3-4 h. Sustained activation of JNK is reported to be linked with cell death (Ventura et al., 2006) . Unlike JNK, we did not detect activation of other stress-related mitogen-activated protein kinases, such as p38, extracellular ligand-regulated kinase (ERK)1/2 and ERK5 (Figures 1c-e) . These results indicated that JNK was activated in Bax/Bak DKO MEFs by etoposide or staurosporine treatment.
Involvement of JNK in etoposide-induced and staurosporine-induced autophagic death of Bax/Bak DKO MEFs As JNK was activated in etoposide-treated and staurosporine-treated Bax/Bak DKO MEFs, we next investigated whether its activation was required for etoposide-induced and staurosporine-induced death of Bax/Bak DKO MEFs. As shown in Figure 2a , etoposide-treated Bax/Bak DKO MEFs became rounded and detached from the culture dish, consistent with our previous findings . These cells showed loss of viability when assessed by staining with propidium iodide (PI; a membrane-impermeable stain for nucleic acid staining; Figures 2b and c), as well as by the colony formation assay (Figure 2d ) and the cell growth assay using Cell Titer Blue (CTB) to measure the metabolic activity of viable cells (Figure 2e ). When Bax/ Bak DKO MEFs were treated with etoposide in the presence of 3-MA (an inhibitor of autophagy through type III phosphoinositide-3 kinase), both morphological changes and cell viability were markedly improved (Figures 2a-e) , which was also consistent with our previous observations . When SP600125 was added instead of 3-MA, cell rounding and detachment were inhibited, but to lesser extent than with 3-MA (Figure 2a) . Similarly, cell viability (assessed by PI staining, colony formation and cell growth) was improved by the addition of JNK inhibitor in a dosedependent manner, but to a lesser extent than that caused by the addition of 3-MA (Figures 2b-e) . Similar results were obtained with staurosporine ( Figure 2f ). In contrast, a p38 inhibitor (SB203580) and an ERK1/2 inhibitor (U0126) did not have any influence on the extent of autophagic cell death (Figure 2c ), a finding consistent with the lack of p38 activation and ERK1/2 activation by etoposide (Figures 1c and d) .
For further confirmation of the role of JNK, a dominant-negative form of JNK was expressed in Bax/ Bak DKO MEFs to specifically inhibit JNK activation ( Figure 2g ). As shown in Figures 2h and i, etoposideinduced autophagic death of Bax/Bak DKO MEFs was significantly suppressed by transfection with the dominant-negative JNK plasmid, but not the empty vector, as assessed by PI staining and the CTB assay, confirming the involvement of JNK in autophagic cell death.
To investigate the involvement of JNK in autophagic cell death from another perspective, we used a genetic approach. Activation of JNK requires phosphorylation of both tyrosine ( 185 Tyr) and threonine ( 183 Thr), and two kinases (SEK1 (also known as MKK4) and MKK7 (SEK2)) are essential for the phosphorylation of these amino-acid residues. Therefore, JNK activation is completely abolished in sek1 À/À mkk7 À/À cells (Nishitai et al., 2004) . As we previously demonstrated that, similar to Bax/Bak DKO MEFs, MEFs overexpressing Bcl-x L die through an autophagic process after etoposide or staurosporine treatment , Bcl-x L was expressed in wild-type (WT) and sek1 À/À mkk7 À/À cells that were treated with etoposide. The WT cells overexpressing Bcl-x L showed resistance to etoposideinduced cell death compared with vector-transfected WT MEFs, but still had a significant decline of viability, which was suppressed by the addition of 3-MA ( Figure 3a) . In contrast, the viability of Bcl-x L -expressing sek1 À/À mkk7 À/À cells was higher than that of Bcl-x L -expressing WT cells and was not influenced by the addition of 3-MA (Figure 3b ). In both types of cells, the level of Bcl-x L expression was equivalent and apoptosis was similarly inhibited (Figure 3c ; data not shown). Therefore, 3-MA-sensitive autophagic cell death was blocked in Bcl-x L -expressing sek1 À/À mkk7 À/À cells. Note that autophagy was activated similarly in both WT and sek1 À/À mkk7 À/À cells (Figure 3d) . Consistent with the above findings, inhibition of autophagy using small interfering RNA (siRNA) for Atg5, which is essential for the induction of autophagy, improved the viability of Bcl-x L -overexpressing WT cells, but not of Bcl-x L -overexpressing sek1 (Figures 3e and f) . Thus, 3-MA-sensitive and Atg5-dependent autophagic cell death was induced in Bcl-x L -overexpressing WT cells, but not in Bcl-x Loverexpressing sek1 À/À mkk7 À/À cells, indicating that activation of JNK was required for the induction of autophagic cell death, consistent with the data shown in Figure 2 .
JNK is activated during autophagic cell death, but not during starvation-induced autophagy Autophagy occurs during autophagic cell death, but is also induced by starvation of cells. We have already demonstrated that JNK is activated during autophagic cell death. We next investigated whether starvationinduced autophagy was also accompanied by the activation of JNK. When Bax/Bak DKO MEFs were starved by incubation in Hanks solution, as described in Materials and methods section, autophagy occurred, as demonstrated by the punctate distribution of green fluorescent protein (GFP)-tagged light chain 3 (LC3; Figure 4a ). As shown in Figure 4b , kinetics of autophagy induction were different between etoposidetreated cells and starved cells. Unlike etoposide treatment, starvation did not induce cell death ( Figure 4c ). As would be expected if it were assumed that autophagy was activated to promote survival during starvation, the death of these cells was enhanced by 3-MA (Figure 4c ). In these cells, the level of JNK activation remained low compared with that in etoposide-treated cells (Figure 4d ), suggesting that activation of JNK occurred with the induction of autophagic cell death but not autophagy for survival.
Co-activation of JNK and autophagy is sufficient to induce autophagic death of Bax/Bak DKO MEFs Having shown that JNK has a crucial role in autophagic cell death, we next investigated whether JNK activation Requirement of JNK for autophagic cell death S Shimizu et al was sufficient to induce autophagic cell death by using an MKK7-JNK fusion protein, in which MKK7a1 and JNK1b1 were connected by the Flag tag (Tsuruta et al., 2004) . Expression of this fusion protein led to constitutive activation of JNK through intramolecular phosphorylation by MKK7 ( Figure 5a ). As shown in Figure 5b , transient expression of MKK7-JNK in WT MEFs induced death, which was inhibited by zVAD-fmk. These findings indicated that WT MEFs underwent apoptosis due to autoactivation of JNK, consistent with numerous previous reports (Gupta et al., 1995) , thus verifying that MKK7-JNK functioned properly in our transfected cells.
The addition of 3-MA enhanced this apoptosis, consistent with other report demonstrating that inhibition of autophagy enhances apoptosis (Boya et al., 2005) . We then introduced this plasmid into DKO MEFs. If activation of JNK was sufficient to induce autophagic cell death, expression of MKK7-JNK should have induced the death of Bax/Bak DKO MEFs. However, despite the similar level of JNK activation in WT and DKO MEFs (Figure 5a) , expression of the MKK7-JNK fusion protein did not induce the death in Bax/Bak DKO MEFs (Figure 5b ), indicating that activation of JNK alone was not sufficient to cause autophagic cell death. 
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We next questioned whether the combination of autophagy and JNK activation could induce autophagic cell death. To elucidate this, we introduced MKK7-JNK plasmid into DKO MEFs and subjected to starvation. Although starvation or MKK7-JNK transfection alone did not induce cell death in DKO MEFs (Figures 4 and 5b) , their combination significantly induced cell death that was greatly inhibited by 3-MA (Figure 5c ), suggesting that co-activation of JNK and autophagy induced autophagic cell death.
JNK does not influence etoposide-induced autophagy in Bax/Bak DKO MEFs As JNK activation was involved in etoposide-and staurosporine-induced autophagic death of Bax/Bak DKO MEFs, we next investigated whether JNK had an influence on autophagic process during the death of these cells. To examine this, GFP-LC3 was first expressed in Bax/Bak DKO MEFs. As a result, etoposide-treated Bax/Bak DKO MEFs showed punctate fluorescence due to the induction of autophagy (Figure 6a ). This punctate fluorescence was inhibited by 3-MA, but not SP600125 (Figures 6a and b) , although both agents inhibited autophagic cell death. Consistently, the majority of etoposide-treated DKO MEFs contained a number of autophagosomes/autolysosomes, observed with electron microscopy, irrespective of addition of the JNK inhibitor (Figure 6c) . Similar results were also obtained using LC-3II formation (Figure 6d ), which is a well-established indicator of autophagy (Kabeya et al., 2000) . Furthermore, accumulation of Beclin 1, a molecule involved in autophagy, was observed at similar levels in etoposide-treated DKO MEFs in the presence and absence of SP600125 (Figure 6d) . Notably, the extent of etoposide-induced autophagy in Bcl-x L -expressing sek1 À/À mkk7 À/À cells was the same as that in Bcl-x L -expressing WT cells, as assessed by LC-3I/II generation ( Figure 3d ). All of these results indicated that inhibition of JNK suppressed autophagic cell death without affecting the occurrence of autophagy in etoposide-treated Bax/Bak DKO MEFs.
Activation of JNK occurs downstream of autophagy in etoposide-treated Bax/Bak DKO MEFs Given that activation of JNK was involved in etoposideand staurosporine-induced autophagic cell death, but not in the process of autophagy itself, we next investigated whether JNK activation occurred downstream of autophagy. We added 3-MA to etoposidetreated Bax/Bak DKO MEFs and then measured the phosphorylation of JNK. Inhibition of autophagy by 3-MA led to a marked reduction in the phosphorylation of JNK in etoposide-treated Bax/Bak DKO MEFs (Figure 7a) , suggesting that the occurrence of autophagy was required for the activation of JNK. To confirm this, we used gene silencing with siRNA to inhibit Atg5. As shown in Figure 7b , silencing of Atg5 inhibited the (Figure 7d ). Therefore, these results indicated that the activation of JNK occurred downstream of the induction of autophagy, and that JNK activation then induced cell death.
Activation of JNK induces autophagic cell death in Bcl-x L -overexpressing HeLa cells
Finally, we questioned whether JNK-mediated autophagic cell death also occurred in apoptosis-resistant human cancer cells. To examine this, we produced apoptosis-resistant HeLa cells by stably overexpressing Bcl-x L (designated as HeLa/Bcl-x L ; Figure 8a ). In contrast to the etoposide-treated Bax/Bak DKO MEFs, which did not die by apoptosis but lost their viability by autophagic cell death (Figure 2b ), HeLa/Bcl-x L cells maintained their viability in the presence of etoposide (Figure 8b ). To elucidate a reason why HeLa/Bcl-x L cells could avoid the autophagic cell death, we examined the induction of autophagy and JNK activation. Induction of autophagy was observed in etoposidetreated HeLa/Bcl-x L cells, as assessed by GFP-LC3 (Figure 8d ) and LC3-II generation (Figure 8e ). In contrast, etoposide-induced JNK activation in Hela/ Bcl-x L cells was much weaker than that in etoposidetreated DKO MEFs (Figure 8f ). Therefore, we hypothesized that the lower levels of JNK activation in Hela/ Bcl-x L cells was responsible for their resistance to autophagic cell death. To examine this possibility, we introduced mkk7-jnk expression plasmid into HeLa/Bclx L cells (Figure 8c ) and treated the cells with etoposide. In response to etoposide, mkk7-jnk-transfected HeLa/ Bcl-x L cells showed autophagy induction (Figures 8d and e) and lost their viability, which was inhibited by 3-MA (Figure 8g ), suggesting the occurrence of autophagic cell death. Taken together, co-activation of autophagy and JNK is crucial for the induction of autophagic cell death. 
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Discussion
Autophagic cell death is thought to be involved in various physiological and pathological events. However, it has long been assessed only from the point of view of morphological changes due to lack of knowledge regarding the molecular events involved in this process, making it difficult to fully understand the role of autophagic cell death in vivo. Recently, Lenardo and colleagues and our group reported different experimental systems, in which autophagic cell death could be activated, which were suitable for investigating the molecular mechanisms of autophagic cell death Yu et al., 2004) . Although the two cellular systems are different, they may share the core machinery of autophagic cell death. Lenardo and colleagues reported that caspase-8, JNK and degradation of catalase were involved in the autophagic death of zVAD-fmk-treated L929 cells (Yu et al., 2004 (Yu et al., , 2006 . Our preliminary studies excluded the involvement of caspase-8 and catalase in the autophagic death of Bax/ Bak DKO cells, as the extent of autophagic cell death was equal in Bcl-x L -overexpressing caspase-8-deficient MEFs and Bcl-x L -overexpressing wild-type MEFs after etoposide stimulation (Shimizu, unpublished data) , and as significant degradation of catalase was not observed in etoposide-treated Bax/Bak DKO MEFs (Shimizu, unpublished data) . In contrast, involvement of JNK seems to be common to both of these autophagic cell death systems. This study showed that: (1) JNK is activated when autophagic cell death is induced in Bax/ Bak DKO MEFs by etoposide and staurosporine, but not when cells are starved; (2) autophagic cell death is suppressed by inhibition of JNK; (3) activation of JNK is required (but not sufficient) for autophagic cell death; and (4) activation of JNK is largely dependent on the Requirement of JNK for autophagic cell death S Shimizu et al autophagic process. These results indicate that JNK is involved in autophagic cell death without influencing the process of autophagy itself, which could be an important piece of information regarding the molecular mechanisms of autophagic cell death. Jun N-terminal kinase belongs to the mitogenactivated protein kinases and is activated by apoptosis signal-regulating kinase 1 (mitogen-activated protein kinase kinase kinase) and SEK1/MKK7 (mitogenactivated protein kinase kinase) when cells are exposed to various stresses (Davis, 2000) . The role of JNK in cell death has long been studied. The activation of JNK is observed when apoptosis is induced by various stressors, including ultraviolet irradiation and tumor necrosis factor, but its function has long been controversial, as it has a pro-apoptotic role in some physiological and pathological conditions, whereas it exerts an antiapoptotic effect in other situations (Davis, 2000) . However, at least, part of this complex issue has been explained by the discovery of different modes of JNK activation (Ventura et al., 2006) . The early transient phase of JNK activation signals for cell survival, whereas sustained JNK activation can trigger apoptotic signals. Sustained activation of JNK has also been reported to mediate reactive oxygen species-induced necrosis (Nakano et al., 2006) . Similarly, we observed the sustained activation of JNK for more than 6 h ( Figure 1 ) in Bax/Bak DKO MEFs undergoing etoposide-induced autophagic cell death. Therefore, sustained JNK activation seems to be harmful for cells.
How does sustained JNK activation induce cell death? In the case of necrosis, JNK has been reported to act as a positive regulator of reactive oxygen species production (Nakano et al., 2006) , although the precise mechanisms involved are unclear. The mechanisms that account for pro-apoptotic signaling by JNK have been studied extensively, and various downstream molecules have been proposed. In neurons, especially in developing neurons, JNK induces apoptosis by activating c-junmediated transcription (Behrens et al., 1999) . In other cells, however, JNK-mediated apoptosis does not require de novo protein synthesis because direct phosphorylation of target molecules induces apoptosis (Tournier et al., 2000) . In any case, JNK functions upstream of apoptotic mitochondrial changes, so that the absence of Bax and Bak blocks JNK-mediated apoptosis. This was confirmed Requirement of JNK for autophagic cell death S Shimizu et al by our findings that over-activation of JNK induced the apoptosis of wild-type MEFs, but not of Bax/Bak DKO MEFs ( Figure 5 ). These data also suggested the possibility that Bcl-2 family members could be direct target(s) of JNK. Actually, JNK induces the expression of BH3-only proteins: Hrk and Bim (Harris and Johnson, 2001) . Jun N-terminal kinase also phosphorylates Bcl-2 family members and promotes pro-apoptotic Bax activity (Kim et al., 2006) , and inhibits various anti-apoptotic Bcl-2 family members, including Bcl-2, Bcl-x L and Mcl-1 (Ito et al., 1997; Park et al., 1997) . In addition, JNK indirectly determines the activation of Bax through its regulation of 14-3-3 (Tsuruta et al., 2004) . Thus, the Bcl-2 family proteins are considered to be likely targets of JNK during the process of apoptosis. With regard to autophagic cell death, we have previously reported that Bcl-x L may regulate the autophagic death of etoposidetreated DKO MEFs , so this molecule might be a target when JNK activates autophagic cell death. The molecular mechanism of JNK activation is another crucial issue with regard to understanding autophagic cell death. We found several pieces of evidence that suggest that the activation of JNK largely occurs in an autophagy-dependent manner: (1) 3-MAmediated inhibition of autophagy suppressed JNK activation (Figure 7a ), (2) silencing of the Atg5 gene also suppressed JNK activation (Figure 7b ), and (3) JNK activation was weaker in Bcl-x L -overexpressing Atg5 À/À MEFs than in Bcl-x L -overexpressing Atg5
MEFs (Figure 7c ). These results indicate that activation of the autophagic process can activate JNK, but induction of autophagy does not necessarily lead to JNK activation. Whether autophagy activates JNK seems to depend on the stimulus, as etoposide and staurosporine, but not starvation, induced JNK activation as shown in this study. Why does JNK activation occur during etoposide/staurosporine-induced autophagic cell death, but not during starvation, although autophagy is activated in both cases? There are two possibilities that can be suggested. We have previously shown that some autophagic proteins, including Atg5 and Beclin 1, are upregulated during etoposide/staurosporine-induced autophagic cell death, but not during starvation . Therefore, a difference in the level of autophagic activity may determine whether JNK activation occurs. Alternatively, other signals in addition to autophagy itself might be required for the activation of JNK. In any case, autophagy may activate endoplasmic reticulum stress or oxidative stress during digestion of endoplasmic reticulum or mitochondria, which may activate JNK signaling pathway. In contrast to our findings, several investigators have described that JNK activation occurred upstream of the induction of autophagy or autophagic cell death when various cells are starved (Wei et al., 2008) , treated with tumor necrosis factor (Cheng et al., 2008) and ceramide (Li et al., 2009) . Possible explanation for this discrepancy might be the difference of the cell types or stimuli used. Tumor necrosis factor and oxidative stress directly activate JNK through tumor necrosis factor receptorassociated factor 2 and apoptosis signal-regulating kinase 1, respectively. In contrast, other signals, such as etoposide, could not directly activate JNK. In such case, JNK activation may be dependent on the environmental and genetic circumstances. Further studies will be necessary to address this issue.
Materials and methods
Antibodies and chemicals
Anti-phospho c-Jun (Ser63)II, anti-stress-activated protein kinase/JNK, anti-phospho p38, anti-phospho stress-activated protein kinase/JNK (Thr183/Tyr185), anti-phospho ERK1/2 and anti-phospho ERK5 antibodies were obtained from Cell Signaling Technologies (Danvers, MA, USA). Anti-Bcl-x L (S-18), anti-active caspase-3 and anti-LC3 polyclonal antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA), Promega (Madison, WI, USA) and MBL (Nagoya, Japan), respectively. A stress-activated protein kinase/JNK Kinase Assay Kit (nonradioactive) was purchased from Cell Signaling Technologies. The inhibitors SP600125 and SB203580 were obtained from Tocris Bioscience (Ellisville, MO, USA). Cell Titer Blue and 3-MA were purchased from ICN Biochemicals (Irvine, CA, USA) and Promega, respectively. Other chemicals were purchased from Wako (Osaka, Japan).
Cell culture and DNA transfection Bax
MEFs were collected from mouse embryos at E14.5, and immortalized with Simian virus 40 T antigen . Mouse embryonic fibroblasts were cultured in Dulbecco's modified Eagle's medium supplemented with 2 mm L-glutamine, 1 mM sodium pyruvate, 0.1 mM non-essential amino acids, 10 mM HEPES/Na þ , (pH 7.4), 0.05 mM 2-mercaptoethanol, 100 U/ml penicillin, 100 mg/ml streptomycin and 10% fetal bovine serum. Sek1/MKK7 double-knockout embryonic stem cells were used as MEF-like cells, and were cultured as described previously (Nishitai et al., 2004) . For starvation of cells, culturing was done in Hanks' balanced salt solution supplemented with 1 mM sodium pyruvate, 10 mM HEPES/Na þ (pH 7.4) and 0.05 mM 2-mercaptoethanol. HeLa/Bcl-x L cells were generated by transfection of the expression plasmid for human Bcl-x L .
The plasmids pCMV5-JNK1 APF (the mammalian expression plasmid for dominant-negative JNK; Gupta et al., 1995) , pCDNA3 MKK7-JNK1 WT (the mammalian expression plasmid for the MKK7-JNK1 fusion gene; Gupta et al., 1995) and pCAGGS-GFP-LC3 (Kabeya et al., 2000) were kindly provided by Drs R Davis, Y Gotoh and N Mizushima, respectively. The pUC-CAGGS expression vector with DNA encoding human Bcl-x L has been described earlier (Shimizu et al., 1996) . Cells (1 Â 10 6 ) were transfected with plasmid DNA using the Amaxa electroporation system according to the supplier's protocol (kit V, program U-20). The transfection efficiency was more than 75%, as assessed by co-transfection with DNA expressing GFP. All siRNAs were produced by Dharmacon Research. The sequences used are as follows (numbers in parentheses indicate nucleotide positions within the respective open reading frames): mouse Atg5 siRNA: 5 0 -AACUUGCUUUACUCUCUAUCA-3 0 (51-71). Cells (1Â10 6 ) were transfected with 10 mg of siRNA using the Amaxa electroporation system.
Analysis of mitogen-activated protein kinase activation
Cells were seeded into 6-well dishes at a density of 3.5 Â 10 6 cells per well. After 24 h, cells were treated with etoposide (20 mM), staurosporine (1 mM), ultraviolet irradiation (100 J/ m 2 ), or were nutrient deprived in the presence or absence of SP600125 (25 mM) and 3-MA (10 mM). The in vitro kinase assay was performed according to the supplier's protocol. Briefly, cell lysates were mixed with c-Jun fusion protein-coated agarose beads at 4 1C for 12 h. After centrifugation and washing, beads were suspended in the Kinase Buffer supplemented with 200 mM ATP for 30 min at 30 1C. Then phosphorylated c-Jun was detected with an anti-phospho-cJun antibody. The activation of JNK was also evaluated by western blotting using an anti-phospho JNK monoclonal antibody. The activation of p38, ERK1/2 and ERK5 was assessed by western blotting.
Cell viability assay
Cells were seeded into 6-well dishes at a density of 3.5 Â 10 6 cells per well. After 24 h, cells were exposed to etoposide (20 mM), staurosporine (1 mM) or were nutrient deprived in the presence or absence of SP600125, SB203580, 3-MA or z-VADfmk at the indicated concentrations. Cells, including floating cells, were then collected and viability was assessed by propidium iodide (PI) staining or CTB assay . Briefly, cells were stained with 1 mM PI for 5 min at room temperature, and then were analyzed using a flow cytometer (FACS Caliber; Becton-Dickinson, Franklin Lakes, NJ, USA). The CTB assay was carried out using Cell Titer Blue assay reagent according to the supplier's protocol.
To examine proliferative activity, MEFs were treated with etoposide, all the cells were recovered, and then, 5000 or 10 000 cells were re-cultured in standard medium in 96-well or 48-well dishes, respectively. Viable cells were measured on the indicated days by the CTB assay . For the colony formation assay, MEFs were treated with etoposide, collected and 2000 cells were seeded into 24-well dishes containing standard medium. After 1 week, the number of colonies was counted .
Western blot analysis
Whole-cell protein extracts were prepared using RIPA buffer, and the protein content was quantified by Lowry's method (Bio-Rad, Tokyo, Japan) according to the manufacturer's instructions. Proteins were then separated by electrophoresis on 15% sodium dodecyl sulfate-polyacrylamide gels and transferred to polyvinylidene fluoride membranes. Filters were treated with the indicated antibodies and proteins were detected using the appropriate horseradish peroxidase-conjugated secondary antibodies and enhanced chemiluminescent reagent (GE healthcare Japan, Tokyo, Japan).
Staining of autophagosomes and lysosomes/autolysosomes
Cells were transfected with 1 mg of GFP-LC3 expression plasmid (Kabeya et al., 2000) . After 24 h, cells were subjected to etoposide treatment or starvation and GFP-LC3 fluorescence was observed under a confocal fluorescence microscope (LSM 510 META, Zeiss Japan, Tokyo, Japan).
Electron microscopy Cells were fixed with 2% paraformaldehyde/2% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4), followed by fixing in 1% OsO 4 . After dehydration, ultrathin sections were stained with uranyl acetate and lead citrate for observation under a JEM 100 CX electron microscope (JEOL, Tokyo, Japan).
